The study evaluates the efficacy of c-MET-CAR-NK cells against METhigh HepG2 HCC and METlow H1299 lung cancer cells, with striking results observed, particularly in the context of HepG2 cells (126). Here, MET is linked to hepatocellular carcinoma.